Paper9710666
Antibiotic-selective environments.
Baquero F and 3 others. Clin Infect Dis, 1998. Cited by 154 papers, by iCite.
Cite this record
ConductScience Library. Antibiotic-selective environments. Papers, record 9710666. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9710666
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Bacteria | Major topic |
| Drug Resistance, Microbial | Major topic |
| Selection, Genetic | Major topic |
| Adaptation, Physiological | |
| Animals | |
| Biological Evolution | |
| Humans | |
| Mutation | |
| beta-Lactamases |
Source PubMed
Cited by74
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 154 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42130556 | Antibiotic resistance: a case of a chronic maxillofacial osteomyelitis complicating an odontogenic cellulitis. | Int J Surg Case Rep | 2026 | https://conductscience.org/library/papers/42130556 | PubMed |
| 42098099 | Host oxidative stress primes mycobacteria for rapid antibiotic resistance evolution. | Nat Commun | 2026 | https://conductscience.org/library/papers/42098099 | PubMed |
| 41557766 | Linking spatial drug heterogeneity to microbial growth dynamics in theory and experiment. | PLoS Comput Biol | 2026 | https://conductscience.org/library/papers/41557766 | PubMed |
| 41457317 | Contrasting pH optima of β-lactamases CTX-M and CMY influence Escherichia coli fitness and resistance ecology. | Appl Environ Microbiol | 2026 | https://conductscience.org/library/papers/41457317 | PubMed |
| 41377970 | Host oxidative stress primes mycobacteria for rapid antibiotic resistance evolution. | Res Sq | 2025 | https://conductscience.org/library/papers/41377970 | PubMed |
| 40859163 | In vitro activity of Eravacycline against carbapenem-resistant gram-negative bacilli and associated risk factors for non-susceptible infections from a tertiary hospital in fujian, China from 2021 to 2024. | BMC Microbiol | 2025 | https://conductscience.org/library/papers/40859163 | PubMed |
| 39770848 | Genetic Characterization, Transmission Pattern and Health Risk Analysis of Intestinal Colonization ESBL-Producing Escherichia coli in Vegetable Farming Population. | Microorganisms | 2024 | https://conductscience.org/library/papers/39770848 | PubMed |
| 39390045 | Predicting future hospital antimicrobial resistance prevalence using machine learning. | Commun Med (Lond) | 2024 | https://conductscience.org/library/papers/39390045 | PubMed |
| 38681947 | [Procalcitonin: The Ideal Biomarker To Guide Initiation, Change and Withdrawal of Antibiotics in Septic Burn Patients?] | Ann Burns Fire Disasters | 2023 | https://conductscience.org/library/papers/38681947 | PubMed |
| 38534682 | In Vitro Microevolution and Co-Selection Assessment of Amoxicillin and Cefotaxime Impact on Escherichia coli Resistance Development. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/38534682 | PubMed |
| 37737468 | Therapeutic potential of low-molecular weight lignin model polymer fractions for treating skin lesions in animals: a pilot study. | Vet Res Commun | 2024 | https://conductscience.org/library/papers/37737468 | PubMed |
| 37289837 | Source-tracking ESBL-producing bacteria at the maternity ward of Mulago hospital, Uganda. | PLoS One | 2023 | https://conductscience.org/library/papers/37289837 | PubMed |
| 36257971 | Biofilm antimicrobial susceptibility through an experimental evolutionary lens. | NPJ Biofilms Microbiomes | 2022 | https://conductscience.org/library/papers/36257971 | PubMed |
| 35815680 | Evolution of β-lactamase-mediated cefiderocol resistance. | J Antimicrob Chemother | 2022 | https://conductscience.org/library/papers/35815680 | PubMed |
| 35411153 | The Risk Factors of Carbapenem-Resistant Klebsiella pneumoniae Infection: A Single-Center Chinese Retrospective Study. | Infect Drug Resist | 2022 | https://conductscience.org/library/papers/35411153 | PubMed |
| 35391738 | Emergence of Resistant Escherichia coli Mutants in Microfluidic On-Chip Antibiotic Gradients. | Front Microbiol | 2022 | https://conductscience.org/library/papers/35391738 | PubMed |
| 35327267 | Nature-Inspired Antimicrobial Surfaces and Their Potential Applications in Food Industries. | Foods | 2022 | https://conductscience.org/library/papers/35327267 | PubMed |
| 34055327 | The integrated management of childhood illness (IMCI) and its potential to reduce the misuse of antibiotics. | J Glob Health | 2021 | https://conductscience.org/library/papers/34055327 | PubMed |
| 33993436 | Impact of spent engine oil contamination on the antibiotic resistome of a tropical agricultural soil. | Ecotoxicology | 2021 | https://conductscience.org/library/papers/33993436 | PubMed |
| 33910990 | Cryptic β-Lactamase Evolution Is Driven by Low β-Lactam Concentrations. | mSphere | 2021 | https://conductscience.org/library/papers/33910990 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9710666
GET https://conductscience.org/api/papers/v1/9710666/cited_by?page=2